Form 13F security
KLRA · KAILERA THERAPEUTICS INC
Class COMMON STOCK
As filed on Form 13F — long US-listed positions only. No shorts, cash, bonds, or non-13F assets appear here.
Filed up to 45 days after quarter end; holdings may have changed since.
Tracked managers holding it
Share and principal positions
| Manager | Quarter | Value | % of portfolio | SH/PRN qty | Put/call |
|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 2026-06-30 | $24M | 0.1% | SH 1,100,000 | — |
| SOROS FUND MANAGEMENT LLC | 2026-06-30 | <$1M | <0.1% | SH 20,000 | — |
Total $25M across 2 of 69 managers.
Sums are across tracked reports, not unique economic ownership.
Filed rows (2) — as filed
| Manager | Class | Put/call | Value | % of portfolio | SH/PRN qty | Source |
|---|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. | COMMON STOCK | — | $24M | 0.1% | SH 1,100,000 | 0000908834-26-000432 |
| SOROS FUND MANAGEMENT LLC | COMMON STOCK | — | <$1M | <0.1% | SH 20,000 | 0000902664-26-003507 |
Quarter-to-quarter notes
Reported change, not a confirmed trade: this compares quarter-end reports filed up to 45 days later, and the position may since have changed. Amendments, corporate actions, and changes in reporting scope can also move these rows. Value change compares period-end reported values; for continuing rows it includes market price movement.
Newly reported by SOROS FUND MANAGEMENT LLC.
Changes appear only where the prior quarter's validated report exists.